Abbvie Inc
ABBV
$198.24-0.62 (-0.31%)
Aug 8, 2025, 10:10 AM
Financials
| 52Week High | 218.66 | 52Week Low | 163.81 |
| Beta | 0.48 | Current Ratio Annual | 0.66 |
| Current Ratio Quarterly | 0.76 | Gross Margin TTM | 70.69 |
| Market Cap | 346.78B | Net Profit Margin TTM | 7.31 |
| Operating Margin TTM | 17.56 | Price To Book | 244.21 |
| Price To Earnings TTM | 82.66 | Price To Free Cash Flow TTM | 22.54 |
| Price To Sales TTM | 6.04 | Quick Ratio Annual | 0.43 |
| Quick Ratio Quarterly | 0.48 | Return On Assets TTM | 3.01 |
| Return On Equity TTM | 95.59 | Return On Investment TTM | 5.66 |
| Revenue Growth3Y | 0.08 | Revenue Growth5Y | 11.11 |
| Revenue Growth Quarterly Yoy | 8.39 | Revenue Growth TTMYoy | 5.45 |
| Revenue Per Share TTM | 32.37 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 3516 | 218 | 295 | 1387 | 1472 | 386 | 1.28B | $258.74B |
| Jun 30, 2025 | 2280 | 47 | 100 | 951 | 827 | 264 | 172.51M | $27.93B |
| Change | 1.24K(35%) | 171(78%) | 195(66%) | 436(31%) | 645(44%) | 122(32%) | 1.11B(87%) | $230.81B(89%) |